Close Menu
  • Home
  • News
  • Lifestyle
  • Law
  • Business
  • Education

Subscribe to Updates

Get the latest creative news from FooBar about art, design and business.

What's Hot

Montana Gov. Signs Bill Reserving $12M of Cannabis Tax Revenues for ‘Habitat Legacy Account’

May 28, 2025

Minnesota Tribe Signs Agreements to Open Adult-Use Dispensaries Off Tribal Land

May 28, 2025

Washington to Issue New Social Equity Cannabis Licenses This Summer

May 27, 2025
Facebook X (Twitter) Instagram
Wednesday, May 28
  • Home
  • Contact
  • Privacy Policy
  • Terms & Conditions
Facebook X (Twitter) Instagram LinkedIn VKontakte
Smoke Professional
  • Home
  • News

    More Than 1,000 Arrested in Sweep of U.K. Weed Grows

    July 8, 2023

    Scotland Calls On UK To End ‘Failed’ Drug War With Decriminalization And Harm Reduction Approach

    July 8, 2023

    Germany’s draft law for first phase of cannabis reform

    July 8, 2023

    High Times Cannabis Cup Illinois: People’s Choice Edition 2023 Kicks Off

    July 8, 2023

    Pennsylvania Committee Advances Expansion to State Medical Cannabis Program

    July 7, 2023
  • Lifestyle

    How Watching the News Can Trigger Anxiety and Panic Attacks

    October 28, 2024

    Record High Cannabis and Hallucinogen Use Among Adults

    October 27, 2024

    Weekend Sleep Catch-Up May Lower Heart Disease Risk by 20%

    October 27, 2024

    Energy Drinks Linked to Poor Sleep Quality and Insomnia

    October 26, 2024

    First Psychedelic Church for Magic Mushrooms

    October 26, 2024
  • Law

    Federal Lawmakers Call for Medicaid Fraud Investigation Into Florida Anti-Cannabis Political Group

    May 26, 2025

    Minnesota Ends Criminal Penalties for Bong Water

    May 23, 2025

    Minnesota Bill to Set Up Adult-Use Cannabis Industry Moves to Governor

    May 22, 2025

    Pennsylvania House Passes Cannabis Legalization Bill

    May 8, 2025

    Nebraska Lawmakers to Reconsider Bill to Implement Voter-Approved Medical Cannabis Law

    May 7, 2025
  • Business

    Montana Gov. Signs Bill Reserving $12M of Cannabis Tax Revenues for ‘Habitat Legacy Account’

    May 28, 2025

    Minnesota Tribe Signs Agreements to Open Adult-Use Dispensaries Off Tribal Land

    May 28, 2025

    Washington to Issue New Social Equity Cannabis Licenses This Summer

    May 27, 2025

    DEA Raid Confiscates Over 29,000 Cannabis Plants in New York

    May 26, 2025

    Arizona Q1 Cannabis Sales Down Nearly 10% from Last Year

    May 22, 2025
  • Education

    CBD and the Aging Population—What Science Says Today

    March 12, 2025

    Wholesale Nootropic Skincare: Boost Your Product Line

    March 10, 2025

    Ideal for Your Business Needs

    March 8, 2025

    A Must-have For Every Smoke Shop

    March 3, 2025

    The Perfect Addition to Your Product Line

    March 1, 2025
Smoke Professional
You are at:Home»News»Congressional Psychedelics Caucus Chairs Applaud FDA For Releasing Research Guidance To Develop Novel Medicines
News

Congressional Psychedelics Caucus Chairs Applaud FDA For Releasing Research Guidance To Develop Novel Medicines

adminBy adminJuly 7, 2023No Comments4 Mins Read
Facebook Twitter Pinterest LinkedIn Tumblr Email
Share
Facebook Twitter LinkedIn Pinterest Email

The bipartisan co-chairs of a congressional psychedelics caucus are touting the Food and Drug Administration’s (FDA) new draft guidance on researching substances like psilocybin and MDMA.

Reps. Lou Correa (D-CA) and Jack Bergman (R-MI), who founded the Psychedelics Advancing Therapies (PATH) Caucus last year, applauded the agency in a joint statement on Wednesday, commending FDA for “their considerable work in releasing the non-binding guidance for comment regarding the clinical study and development of psychedelic therapies for those suffering from mental and behavioral health conditions.”

They noted that FDA has already designated psilocybin and MDMA as “breakthrough therapies” for the treatment of severe depression and post-traumatic stress disorder (PTSD), respectively.

“As our country continues to suffer tragic rates of suicide and opioid overdose deaths, which disproportionately impact our Nation’s military Veterans, it is critical that policymakers such as those in our caucus pursue additional pragmatic measures—alongside the relevant agencies—to ensure that those who would benefit most from these potentially lifesaving therapies can get access as soon as possible,” the congressmen said.

The release of the draft guidance came just days after another set of bipartisan lawmakers filed a bill that specifically asked the agency to take that step.

Reps. Dan Crenshaw (R-TX), Mariannette Miller-Meeks (R-IA) and Ro Khanna (D-CA) also reacted to the FDA move last week, crediting it for making progress in a way that was responsive to their legislation.

FDA’s draft guidance provides scientists with a framework to carry out research that could lead to the development of psychedelic medicines. A 60-day public comment period is open for interested parties to submit feedback on how final guidance should be shaped.

Interest in psychedelics has grown exponentially over recent years as cities and states across the country have moved to promote research, remove criminal penalties and regulate access to entheogenic substances.

The agency’s draft guidance “describes basic considerations throughout the drug development process including trial conduct, data collection, subject safety and new drug application requirements,” FDA said.

The related bipartisan bill filed last week called on the secretary of the U.S. Department of Health and Human Services (HHS), acting through the FDA commissioner, to “issue for public comment draft guidance on considerations for conducting clinical trials for psychedelic assisted therapy, including how those seeking an investigational use exemption for such clinical trials should request interactive support by the Food and Drug Administration.”

If enacted, it would have required FDA to produce that draft guidance within 180 days. But the agency was evidently prepared to release it much sooner. The bill would also mandate FDA to finalize its guidance 180 days after the draft document’s publication, so lawmakers may still be interested in advancing the measure with that provision.

—
Marijuana Moment is tracking more than 1,000 cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.

Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.
—

The FDA’s Federal Register filing notes that a public docket has been made available for people to submit comments on the draft guidance.

The move is timely, as lawmakers and health officials have shown serious interest in quickly expanding research into psychedelics as studies have revealed their potential in the treatment of conditions such as severe depression, post-traumatic stress disorder and addiction.

Marijuana Moment asked HHS Secretary Xavier Becerra last month about the department’s current thinking around psychedelics policy, and he said he needed to “defer” to the expertise of the National Institute on Drug Abuse (NIDA), which also falls under his agency, “because I want to make sure that I touch base with what they’ve been doing on that.”

Last month, NIDA called for research into the impact of evolving laws around psychedelics, including the effects of allowing regulated access to substances like psilocybin.

NIDA separately announced in May that it is soliciting proposals for a series of research initiatives meant to explore how psychedelics could be used to treat drug addiction, with plans to provide $1.5 million in funding to support relevant studies.

Photo elements courtesy of carlosemmaskype and Apollo.

Source link

Applaud Caucus Chairs Congressional Develop FDA Guidance Medicines Psychedelics Releasing research
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
Previous ArticleNew York Cannabis: Early Unforced Errors in Enforcement
Next Article Moxie Launches in Ohio | High Times
admin
  • Website

Related Posts

Curaleaf Wins First Massachusetts Cannabis Research License

November 20, 2024

Cannabis Research Institute Launches in Illinois

November 19, 2024

American Institute of CPAs Asks Feds for Guidance on Cannabis Rescheduling

October 24, 2024

Comments are closed.

Our Picks

Montana Gov. Signs Bill Reserving $12M of Cannabis Tax Revenues for ‘Habitat Legacy Account’

May 28, 2025

Minnesota Tribe Signs Agreements to Open Adult-Use Dispensaries Off Tribal Land

May 28, 2025

Washington to Issue New Social Equity Cannabis Licenses This Summer

May 27, 2025

Federal Lawmakers Call for Medicaid Fraud Investigation Into Florida Anti-Cannabis Political Group

May 26, 2025
  • Facebook
  • Twitter
  • Pinterest
  • Instagram
  • YouTube
  • Vimeo
Don't Miss
Business

Montana Gov. Signs Bill Reserving $12M of Cannabis Tax Revenues for ‘Habitat Legacy Account’

By adminMay 28, 20250

Montana Gov. Greg Gianforte (R) signed a law directing about $12 million of annual tax…

Minnesota Tribe Signs Agreements to Open Adult-Use Dispensaries Off Tribal Land

May 28, 2025

Washington to Issue New Social Equity Cannabis Licenses This Summer

May 27, 2025

Federal Lawmakers Call for Medicaid Fraud Investigation Into Florida Anti-Cannabis Political Group

May 26, 2025

Subscribe to Updates

Get the latest creative news from Smoke Unlimited about Weed & CBD vaping.

From Our Partners
About Us
About Us

Get all the current news stories, latest trends and legislation regarding cannabidiol, products, usages and its benefits. So don’t miss out any buzz and stay tuned! We offer a minute to minute updates regarding Marijuana industry.

Facebook X (Twitter) Instagram Pinterest
Our Picks

Montana Gov. Signs Bill Reserving $12M of Cannabis Tax Revenues for ‘Habitat Legacy Account’

May 28, 2025

Minnesota Tribe Signs Agreements to Open Adult-Use Dispensaries Off Tribal Land

May 28, 2025

Washington to Issue New Social Equity Cannabis Licenses This Summer

May 27, 2025
Sponsors
Copyright © 2025. SmokeProfessional
  • Home
  • Contact
  • Privacy Policy
  • Terms & Conditions

Type above and press Enter to search. Press Esc to cancel.